Home > Insider Trading > Filing (0001209191-23-033340)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651311	Merus N.v.	MRUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791115	Harry Shuman	C/O Merus N.v. Uppsalalaan 17 Utrecht P7 3584 CT	Vp Controller, Pao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2023-06-01	2,500	$0.00	6,017	No	4	M	Direct
Common Shares	Disposition	2023-06-01	575	$21.48	5,442	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Restricted Share Unit	Disposition	2023-06-01	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,500			No	4	M	Direct

Footnotes

The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
Restricted stock units vest in four equal installments on each of June 1, 2022, December 1, 2022, June 1, 2023 and December 1, 2023. Restricted stock units convert into Issuer common stock on a one-for-one basis. There is no applicable conversion or exercise price.